The aim of this study was to explore the potential involvement of IL-17A in the pathogenesis of SSc by the analysis of the in vitro expression of IL-17A and pro-fibrotic cytokines in peripheral blood mononuclear cells (PBMCs) from subjects with SSc and the effects of IL-17A neutralizing antibodies. The gene discussed is IL17A; the disease is systemic sclerosis.